To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The aim is to examine whether pharmacological interventions with thiazolidinedione and
angiotensin converting enzyme (ACE) inhibitors can reverse pre-clinical vasculopathy in newly
diagnosed diabetic and IGT individuals.
Phase:
Phase 3
Details
Lead Sponsor:
Universiti Sains Malaysia University of Science Malaysia